ACKR3 and neoplasm: Meanwhile, TECs use various chemokine receptors (CXCR) including atypical chemokine receptor 1 (ACKR1), ACKR3, CXCR7, CXCR4, and chemokine (C-C motif) receptor 2 (CCR2) as markers of TECs to support tumor cells progression in numerous cancer types, recently reviewed in [40]).